CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Book Value History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Adjusted Book Value | 122.12 | 99.14 | 78.55 | 66.80 |
What is the latest Book Value ratio of CORONA REMEDIES ?
| Year | Book Value |
|---|---|
| Mar2026 | 122.12 |
| Mar2025 | 99.14 |
| Mar2024 | 78.55 |
| Mar2023 | 66.80 |
How is Book Value of CORONA REMEDIES Trending?
| Years | Book Value | % Change | |
|---|---|---|---|
| Mar2026 | 122.12 | 23.18 | |
| Mar2025 | 99.14 | 26.21 | |
| Mar2024 | 78.55 | 17.59 | |
| Mar2023 | 66.80 | - | |
Compare Book Value of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹14,685.2 Cr | 3.5% | 12% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 3.5% |
12% |
|
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses